Manufacturers are under pressure to shorten manufacturing timescales and reducing the time needed for release testing is one contributor.
Industrialising the manufacture of cell & gene therapies.
Moving the gene sequencing sector beyond its current ‘cottage industry’ status and making the approach available for commercial mass use.
Sagentia offers a unique blend of core skills, facilitating progress and innovation.
Our expertise across the entire product development lifecycle. The knowledge of the science, technologies.
Our ability to work alongside your development teams or to work independently.
Our curiosity, passion and collaborative approach in approaching new development challenges.
We are very flexible in our business model and have a client-friendly attitude to IP ownership.
Complete our contact form for an informal chat with one of our technology consultants